Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1991-02-15
1992-06-30
Doll, John
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
435 7021, 4351722, 43524027, 424 858, 935104, 935107, C12N 520, C07K 1528
Patent
active
051262622
ABSTRACT:
Specific antibody of the invention is capable of differentiating between malignant and benign tumors, and is obtained by culturing hybridoma cells prepared from tumor cells treated with a certain anti-tumor substance.
REFERENCES:
patent: 4522918 (1985-06-01), Schlom et al.
Chemical Abstracts, vol. 101, No. 21, Nov. 19, 1984, p. 560; "Detection and Enhancement (By Recombinant Interferon) of Carcinoma Cell Surface Antigens Using Monoclonal Antibodies".
Chemical Abstracts, vol. 99, No. 15, Oct. 10, 1983, p. 493; "Differential Regulation of HLA-DR mRNAs and Cell Surface Antigens by Interferon".
Giacomini et al.; The Journal of Immunology, vol. 133, No. 3, Sep., 1984; pp. 1649-1655; "Modulation by Recombinant DNA Leukocyte (.alpha.) and Fibroblast (.beta.) Interferons of the Expression and Shedding of HLA- and Tumor-Associated Antigens by Human Melanoma Cells".
Koch et al.; The Journal of Immunology, vol. 132, No. 3, Mar. 1984; pp. 1361-1369; "Ia Antigens and Associated Invariant Chain are Induced Simultaneously in Lines of T-Dependent Mast Cells by Recombinant Interferon-.gamma..sup.1 ".
Chemical Abstracts; vol. 101, No. 13, Sep. 24, 1984, p. 484; "Enhanced Expression of Surface Tumor-Associated Antigens on Human Breast and Colon Tumor Cells After Recombinant Human Leukocyte.alpha.Interferon Treatment".
Wilson et al.; Int. J. Cancer, vol. 28, 1981, pp. 293-300; Distribution and Molecular Characterization of a Cell-Surface and a Cytoplasmic Antigen Detectable in Human Melanoma Cells with Monoclonal Antibodies.
Khan et al., Cancer Res. 43, 1983, pp. 5868-5872.
Bumol et al., Hybridoma 1(3) 1982, pp. 283-292.
Steplewski, Transplantation Proc. XII, 1980, pp. 384-387.
Morgan et al. Cancer Res. 43, 1983, pp. 3155-3159.
Herlyn et al., Cancer Investigation 1(3), 1983, pp. 215-224.
Dippold et al., PNAS 77, 1980, pp. 6114-6118.
Greiner et al., Cancer Res. 44, 1984, pp. 3208-3214.
Reisfeld, Nature 298, 1982, p. 325.
Eisinger et al., PNAS 79, 1982, pp. 2018-2022.
Ueda et al., "Cell surface antigens of human renal cancer . . . MBB", PNAS, vol. 78(8), 1981, pp. 5122-5126.
Cairncross et al., "Cell surface antigens of human astrocytoma . . . MAB", PNAS, vol. 79, 1982, pp. 5641-5645.
Imai et al., "Differential effect of IFN on expression of tumor associated antigen . . . cells", J. Immunol., vol. 127(2), 1981, pp. 505-508.
Liao et al., "Effect of Glutaraldehyde treatment on human melanoma cells . . . antigens", Cancer Immunol. Immunother., 1981, vol. 11, pp. 23-29.
Proc. Natl. Acad. Sci. U.S., vol. 75, pp. 3405-3409, 6215-6219, 1978.
Proc. Natl. Acad. Sci. U.S., vol. 77, pp. 6114-6118, 1980.
Science, vol. 212, U.S., vol. 212, pp. 53-55, 1981.
Proc. Natl. Acad. Sci., U.S., vol. 79, pp. 3265-3269, 3082-3086, 1982.
Houghton et al.; J. Exp. Med., vol. 156; Dec. 1982, pp. 1755-1766; "Surface Antigens of Melanocytes and Melanomas".
Houghton et al.; J. Exp. Med., vol. 160; Jul. 1984, pp. 255-269; "Surface Antigens of Melanoma and Melanocytes".
Koprowski et al.; Proceedings of the International Symposium on the Impact of Biotechnology on Diagnostics held in Rome, Italy, Apr. 16-18, 1985; "Biotechnology in Diagnostics", pp. 135-146.
Matsui et al., Characterization of a Monoclonal . . . J. of Immunology, (Sep. 15, 1987), vol. 139, pp. 2088-2095.
Natali et al., Human Melanoma . . . , in Cutaneous Melanoma and Precursor Lesions, eds. Reuiter et al. (Martinus Nihjoff Publ., Boston, 1984), pp. 19-37.
Ferrone Soldano
Matsui Masashi
Budens Robert D.
Doll John
Suntory Limited
LandOfFree
Monoclonal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1863359